Previous Close | 1.4000 |
Open | 1.3000 |
Bid | 1.5500 |
Ask | 1.7500 |
Strike | 2.50 |
Expire Date | 2024-07-19 |
Day's Range | 1.3000 - 1.5500 |
Contract Range | N/A |
Volume | |
Open Interest | 973 |
NATICK, Mass., June 28, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced the pricing of an underwritten public offering of 14,406,508 shares of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase 14,406,508 Shares (the "Warrants" and, together with the Shares, the "Securities") at a public offering price of $1.20 per share, for total gross proceeds of $17.3 million, before deduc
NATICK, Mass., June 26, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase Shares (the "Warrants" and, together with the Shares, the "Securities").
NATICK, Mass., June 20, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program. Vital signs and physical activity were tracked in real-time with the Allurion App, Connected Scale, and Health Tracker, and follow-up was provided through the AI-powered Allurion Virtual Care Suite.